Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
42 hedge funds and large institutions have $24.4M invested in Psychemedics Corporation in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 7 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
2% more capital invested
Capital invested by funds: $23.8M → $24.4M (+$579K)
7% less funds holding
Funds holding: 45 → 42 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q4 2019 in Review
42 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2019, worth a combined $24.4M — up 2.4% from $23.8M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PMD and 4 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 14 added.
The largest buyer was Ancora Advisors, adding an estimated $389K. The largest seller was DePrince Race & Zollo Inc (DRZ), exiting entirely with an estimated $399K sold.
- 42 institutional investors held Psychemedics Corporation (PMD) as of Q4 2019, down from 45 in Q3 2019.
- Funds reported $24.4M of Psychemedics Corporation stock for Q4 2019, up 2.4% quarter-over-quarter.
- 4 funds opened new Psychemedics Corporation positions in Q4 2019 and 7 closed out, a net change of -3 holders.
- The largest Psychemedics Corporation buyer in Q4 2019 was Ancora Advisors, an estimated $389K added.
- The largest Psychemedics Corporation seller in Q4 2019 was DePrince Race & Zollo Inc (DRZ), an estimated $399K sold.
Based on aggregated 13F filings for Q4 2019.